Biocon Launches Haselmeier’s Insulin Pen in India

One of Asia’s premier biotechnology companies, Biocon recently announced the launch of Haselmeier’s INSUPen in India. The INSUPen is a reusable insulin pen based on Haselmeier’s popular i-pen technology.

Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen for use with Biocon’s insulin and insulin analogues.

“The INSUPen provides diabetic patients with user-friendly features at an affordable cost. Haselmeier is proud to work with Biocon, a premier biotechnology company, on this important programme to develop and supply INSUPen and we look forward to a long and successful partnership,” said Volker Wirth, Director Business Development and Marketing at Haselmeier.

Rakesh Bamzai, President, Marketing at Biocon added: “I am confident that INSUPen will be a delight for patients and a value enhancer for all stakeholders.”

Biocon has recruited a team of 125 Diabetic Care Advisors across India to support its existing helpline for diabetics, which offers complementary wide-ranging support for this device including at-home product demos, counseling on lifestyle changes and answers to product-related queries.

Tags: insulin delivery, insulin pen, INSUPen